Angwin, C., Jenkinson, C., Jones, A., Jennison, C., Henley, W., Farmer, A., . . . Hattersley, A. (2020). TriMaster: Randomised double-blind crossover study of a DPP4 inhibitor, SGLT2 inhibitor and thiazolidinedione as second-line or third-line therapy in patients with type 2 diabetes who have suboptimal glycaemic control on metformin treatment with or without a sulfonylurea—a MASTERMIND study protocol. BMJ Open.

Angwin, Catherine, et al. "TriMaster: Randomised Double-blind Crossover Study of a DPP4 Inhibitor, SGLT2 Inhibitor and Thiazolidinedione As Second-line or Third-line Therapy in Patients With Type 2 Diabetes Who Have Suboptimal Glycaemic Control On Metformin Treatment With or Without a Sulfonylurea—a MASTERMIND Study Protocol." BMJ Open 2020.

Angwin, Catherine, et al. "TriMaster: Randomised Double-blind Crossover Study of a DPP4 Inhibitor, SGLT2 Inhibitor and Thiazolidinedione As Second-line or Third-line Therapy in Patients With Type 2 Diabetes Who Have Suboptimal Glycaemic Control On Metformin Treatment With or Without a Sulfonylurea—a MASTERMIND Study Protocol." BMJ Open 2020.